Nidufexor, a non-bile acid FXR agonist, decreases ALT and hepatic fat fraction in patients with NASH after 12 weeks dosing

Autor:	Richard Aspinall, Mustafa Shennak, George Stocia, Dean Quinn, Lali Javashvili, Valentina Molteni, Chinweike Ukomadu, Bindi Sohal, Yiming Zhang, Miljen Martic, Alexandre Avrameas, Sheena Kao, Jacques Herve, Rachel Soon, Michael Badman
Rok vydání:	2020
Předmět:	Hepatology
Zdroj:	Journal of Hepatology. 73:S4-S5
ISSN:	0168-8278
DOI:	10.1016/s0168-8278(20)30570-5
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::e14a95d22f285947085a85d252cf4298 https://doi.org/10.1016/s0168-8278(20)30570-5 Zobrazit plný text záznamu Full Text from ScienceDirect